Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 95
of 5Next
1:

Specific antibody response of mice after immunization with COS-7 cell derived avian influenza virus (H5N1) recombinant proteins.

Horthongkham N, Srihtrakul T, Athipanyasilp N, Siritantikorn S, Kantakamalakul W, Poovorawan Y, Sutthent R.

J Immune Based Ther Vaccines. 2007 Oct 3;5:10.

PMID: 17910773 [PubMed - in process]

2:

Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus.

Wei CJ, Xu L, Kong WP, Shi W, Canis K, Stevens J, Yang ZY, Dell A, Haslam SM, Wilson IA, Nabel GJ.

J Virol. 2008 Jul;82(13):6200-8. Epub 2008 Apr 16.

PMID: 18417563 [PubMed - indexed for MEDLINE]

4:

[Construction and immunogenicity study of DNA vaccine expressing human H5N1 influenza virus hemagglutinin]

Huan LF, Yao LH, Chen AJ, Cheng CS, Jia RQ, Tian Q, Bo H, Guo JQ, Wang M, Shu YL, Zhang ZQ.

Bing Du Xue Bao. 2007 Sep;23(5):366-70. Chinese.

PMID: 17969853 [PubMed - indexed for MEDLINE]

5:

Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria.

Shen S, Mahadevappa G, Oh HL, Wee BY, Choi YW, Hwang LA, Lim SG, Hong W, Lal SK, Tan YJ.

J Med Virol. 2008 Nov;80(11):1972-83.

PMID: 18814259 [PubMed - indexed for MEDLINE]

6:

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID: 17870216 [PubMed - indexed for MEDLINE]

7:

Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody.

He Q, Velumani S, Du Q, Lim CW, Ng FK, Donis R, Kwang J.

Clin Vaccine Immunol. 2007 May;14(5):617-23. Epub 2007 Mar 7.

PMID: 17344345 [PubMed - indexed for MEDLINE]

8:

Surveillance activities and molecular analysis of H5N1 highly pathogenic avian influenza viruses from Thailand, 2004-2005.

Buranathai C, Amonsin A, Chaisigh A, Theamboonlers A, Pariyothorn N, Poovorawan Y.

Avian Dis. 2007 Mar;51(1 Suppl):194-200.

PMID: 17494553 [PubMed - indexed for MEDLINE]

9:

Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans.

Cauthen AN, Swayne DE, Schultz-Cherry S, Perdue ML, Suarez DL.

J Virol. 2000 Jul;74(14):6592-9.

PMID: 10864673 [PubMed - indexed for MEDLINE]

10:

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.

Vaccine. 2007 May 10;25(19):3871-8. Epub 2007 Feb 15.

PMID: 17337102 [PubMed - indexed for MEDLINE]

11:

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

Bender C, Hall H, Huang J, Klimov A, Cox N, Hay A, Gregory V, Cameron K, Lim W, Subbarao K.

Virology. 1999 Feb 1;254(1):115-23.

PMID: 9927579 [PubMed - indexed for MEDLINE]

12:

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.

Chen Z, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T, Tamura S.

Vaccine. 1999 Feb 26;17(7-8):653-9.

PMID: 10067670 [PubMed - indexed for MEDLINE]

13:

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ.

PLoS Med. 2007 Feb;4(2):e59.

PMID: 17298168 [PubMed - indexed for MEDLINE]

15:

A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.

Song H, Nieto GR, Perez DR.

J Virol. 2007 Sep;81(17):9238-48. Epub 2007 Jun 27.

PMID: 17596317 [PubMed - indexed for MEDLINE]

16:

[Construction and experimental immunity of recombinant replication-competent canine adenovirus type 2 expressing hemagglutinin gene of H5N1 subtype tiger influenza virus]

Gao YW, Xia XZ, Wang LG, Liu D, Huang G.

Wei Sheng Wu Xue Bao. 2006 Apr;46(2):297-300. Chinese.

PMID: 16736595 [PubMed - in process]

17:

Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus.

De BK, Shaw MW, Rota PA, Harmon MW, Esposito JJ, Rott R, Cox NJ, Kendal AP.

Vaccine. 1988 Jun;6(3):257-61.

PMID: 3048009 [PubMed - indexed for MEDLINE]

19:

Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.

Puthavathana P, Auewarakul P, Charoenying PC, Sangsiriwut K, Pooruk P, Boonnak K, Khanyok R, Thawachsupa P, Kijphati R, Sawanpanyalert P.

J Gen Virol. 2005 Feb;86(Pt 2):423-33.

PMID: 15659762 [PubMed - indexed for MEDLINE]

20:

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.

Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z.

Biochem Biophys Res Commun. 2006 May 19;343(4):1124-31. Epub 2006 Mar 23.

PMID: 16580631 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 95
of 5Next